News Depression and Mental Health News Blog Abilify Approved for Adolescents With Schizophrenia | Abilify Approved for Adolescents With Schizophrenia |
|
|
|
The U.S. Food and Drug Administration has approved the Bristol-Myers Squibb antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia, the company said Tuesday. The FDA first approved the drug to treat schizophrenia in adults in November 2002. More than 12.5 million U.S. prescriptions for the medication have since been written, the drug maker said. Expanded approval to teens was based on a six-week, 13-nation study that "demonstrated significant improvement with Abilify compared to placebo," a company statement said. Read on
Please Enter New Tags Separated By Comma's
Or Close 
      |
Most recent comments
| I am in a dark place holding my candlelight...I feel like bl... |
| More... |
| I feel like I never sleep. I just keep replaying things in m... |
| More... |
Popular Pages
Popular this week
Syndicate
Tag Cloud
adhd adolescents alcoholism anorexia antidepressant Antidepressants anxiety bipolar disorder bulimia bullying caregiving Celexa childhood depression children and depression christmas cognitive behavioral therapy college students depressed teens depression depression and celebrities depression and teenagers depression screening depression symptoms depression test depression treatment elderly exercise family therapy fitness gastrointestinal bleeding health insurance holiday blues holiday depression holidays meditation mental health mental illness military online support group post traumatic stress disorder postpartum depression posttraumatic stress disorder pregnancy prescription drugs prozac psychiatrist psychologist psychotherapy ptsd risk factors sad schizophrenia seasonal affective disorder seniors soldiers SSRIs stress suicide suicide rates support group talk therapy teenagers teens teens and depression therapist therapy virtual iraq wellbutrin wellness winter blues women and depression work work and stress workplace zyprexa
Copyright© Deborah Gray
Except where otherwise noted, this work is licensed under a Creative Commons License.
This information is meant to support, not replace, the relationship between a reader and his/her doctor. We do not collect, distribute, or sell any information about visitors to this site. And we do not retain or re-distribute personal information, including the email address, of anyone who writes to us. Wing of Madness accepts no corporate subsidy of any kind.